Blinded Independent Central Review of Progression-Free Survival in Phase III Clinical Trials: Important Design Element or Unnecessary Expense?

Progression-free survival is an important end point in advanced disease settings. Blinded independent central review (BICR) of progression in randomized clinical trials has been advocated to control bias that might result from errors in progression assessments. However, although BICR lessens some po...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Dodd, Lori E., Korn, Edward L., Freidlin, Boris, Jaffe, C. Carl, Rubinstein, Lawrence V., Dancey, Janet, Mooney, Margaret M.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Clinical Oncology 2008
Témata:
Statistics in Oncology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2654812/
https://ncbi.nlm.nih.gov/pubmed/18669467
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.16.1711
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky